Sign In
Buy DGX
$233.72
+1.77 (+0.763%)
At Close: Aug 04, 2026
Quest Diagnostics launches Alzheimer's blood test for consumers
07:10am, Monday, 31'st Jul 2023
Quest Diagnostics on Monday launched the first direct-to-consumer blood test to detect abnormal levels of beta amyloid, a key Alzheimer's protein which can appear years before dementia symptoms arise.
Quest Diagnostics (DGX) Surpasses Q2 Earnings and Revenue Estimates
09:25am, Wednesday, 26'th Jul 2023
Quest Diagnostics (DGX) came out with quarterly earnings of $2.30 per share, beating the Zacks Consensus Estimate of $2.23 per share. This compares to earnings of $2.36 per share a year ago.
Quest Diagnostics beats profit estimates as routine testing picks up
07:56am, Wednesday, 26'th Jul 2023
Laboratory operator Quest Diagnostics Inc beat estimates for quarterly profit on Wednesday, as people returned for regular checkups and tests that were delayed during a large part of the COVID-19 pand
Final Trades: Quest Diagnostics, Keysight & more
02:32pm, Tuesday, 18'th Jul 2023
The "Halftime Report" traders give their top picks to watch for the second half.
Quest Diagnostics (DGX) to Post Q2 Earnings: What's in Store?
01:35pm, Tuesday, 18'th Jul 2023
Quest Diagnostics (DGX) second-quarter results are likely to have reflected the solid base business performance and benefits from acquisitions.
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
12:50pm, Tuesday, 18'th Jul 2023
Investors are optimistic about Quest Diagnostics (DGX) on stronger base volume recovery and growth from strategic acquisitions.
Quest Diagnostics (DGX) Brings New Test for Prostate Cancer
08:53am, Friday, 14'th Jul 2023
Quest Diagnostics (DGX) collaborates with Envision Sciences to bring a novel prosate cancer biomarker test.
Quest Diagnostics' (DGX) New Pact to Get Home Fertility Test
11:45am, Monday, 10'th Jul 2023
The Proov Confirm home collection kit can be purchased now on Quest Diagnostics' questhealth.com for $29.
Quest Diagnostics (DGX) Presents New Data on Disease Testing
12:12pm, Monday, 03'rd Jul 2023
Quest Diagnostics (DGX) is dedicated to create cutting-edge laboratory tests to help assess patient risk for dementia and other degenerative diseases.
Quest Diagnostics' (DGX) New Buyout Expands Cancer Portfolio
02:06pm, Thursday, 22'nd Jun 2023
Quest Diagnostics (DGX) will use MRD technology to create new blood-based clinical lab services for solid tumour cancers that will be available starting in 2024.
Quest Diagnostics to Release Second Quarter 2023 Financial Results on July 26, 2023
10:00am, Wednesday, 21'st Jun 2023
SECAUCUS, N.J. , June 21, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it will report second quarter
Quest Diagnostics (DGX) Partners to Offer New Testing Service
12:31pm, Tuesday, 20'th Jun 2023
Quest Diagnostics' (DGX) latest test indicates how different genes and their variants affect how a person reacts to drugs.
Quest Diagnostics' (DGX) Contract Wins Aid Amid Volume Woes
12:29pm, Tuesday, 06'th Jun 2023
Quest Diagnostics (DGX) succeeds on contract wins in its reference and professional lab services offerings.
Quest Diagnostics to Speak at the Jefferies Global Healthcare Conference
11:19am, Friday, 02'nd Jun 2023
SECAUCUS, N.J. , June 2, 2023 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at th
Reasons to Retain Quest Diagnostics (DGX) Stock for Now
09:55am, Friday, 02'nd Jun 2023
Investors are optimistic about Quest Diagnostics (DGX) on the strength of the base business performance and its strategies to accelerate growth.
